Roivant Sciences Total Assets increased by 9.2% to $5.71B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.0%, from $5.44B to $5.71B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 17.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth generally indicates business expansion, while a decline may suggest asset liquidation or a contraction in business scale.
This is the sum of all current and non-current assets owned by the company, representing the total resource base availab...
Universal financial metric used by all public companies to define the size of the balance sheet.
total_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.45B | $3.10B | $2.80B | $2.59B | $2.60B | $2.22B | $2.20B | $2.39B | $2.14B | $2.07B | $7.31B | $7.22B | $6.50B | $6.21B | $5.79B | $5.44B | $5.03B | $5.06B | $5.23B | $5.71B |
| QoQ Change | — | +26.4% | -9.8% | -7.7% | +0.6% | -14.8% | -0.6% | +8.5% | -10.6% | -3.3% | +254.0% | -1.2% | -10.1% | -4.5% | -6.7% | -6.1% | -7.4% | +0.6% | +3.2% | +9.2% |
| YoY Change | — | — | — | — | +5.9% | -28.6% | -21.3% | -7.6% | -17.8% | -6.8% | +231.9% | +202.2% | +204.0% | +200.5% | -20.8% | -24.7% | -22.5% | -18.4% | -9.8% | +5.0% |